MX2020012254A - Composiciones veterinarias y sus usos para controlar las deficiencias de hierro en mamiferos no humanos. - Google Patents

Composiciones veterinarias y sus usos para controlar las deficiencias de hierro en mamiferos no humanos.

Info

Publication number
MX2020012254A
MX2020012254A MX2020012254A MX2020012254A MX2020012254A MX 2020012254 A MX2020012254 A MX 2020012254A MX 2020012254 A MX2020012254 A MX 2020012254A MX 2020012254 A MX2020012254 A MX 2020012254A MX 2020012254 A MX2020012254 A MX 2020012254A
Authority
MX
Mexico
Prior art keywords
human mammals
veterinary compositions
controlling iron
iron deficiencies
deficiencies
Prior art date
Application number
MX2020012254A
Other languages
English (en)
Inventor
Hamadi Karembe
Florence Guimberteau
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Publication of MX2020012254A publication Critical patent/MX2020012254A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición veterinaria que comprende un complejo de hierro como único ingrediente activo y un polímero soluble en agua. La invención se refiere además al uso de dicha composición para controlar las deficiencias de hierro y/o los estados anémicos en un mamífero no humano.
MX2020012254A 2018-05-16 2019-05-16 Composiciones veterinarias y sus usos para controlar las deficiencias de hierro en mamiferos no humanos. MX2020012254A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18305607 2018-05-16
PCT/EP2019/062700 WO2019219855A1 (en) 2018-05-16 2019-05-16 Veterinary compositions and the uses thereof for controlling iron deficiencies in non-human mammals

Publications (1)

Publication Number Publication Date
MX2020012254A true MX2020012254A (es) 2021-04-13

Family

ID=62386315

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020012254A MX2020012254A (es) 2018-05-16 2019-05-16 Composiciones veterinarias y sus usos para controlar las deficiencias de hierro en mamiferos no humanos.

Country Status (14)

Country Link
US (1) US20210220319A1 (es)
EP (1) EP3793516B1 (es)
JP (1) JP2021523183A (es)
KR (1) KR20210009332A (es)
CN (1) CN112203639A (es)
AU (1) AU2019270428B2 (es)
BR (1) BR112020023212A2 (es)
CA (1) CA3099827A1 (es)
CL (1) CL2020002956A1 (es)
CO (1) CO2020015585A2 (es)
MX (1) MX2020012254A (es)
PH (1) PH12020551926A1 (es)
UA (1) UA128480C2 (es)
WO (1) WO2019219855A1 (es)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1183940A (en) * 1966-10-22 1970-03-11 Fisons Pharmaceuticals Ltd Ferric Hydroxide Complexes
JPS5176436A (ja) * 1974-12-24 1976-07-02 Kumiai Chemical Industry Co Dobutsuyohinketsuyobo chiryozai
JPS53148538A (en) * 1977-05-27 1978-12-25 Nippon Kayaku Co Ltd Preventive for anemia of warm-blooded animal
ES2236300T3 (es) * 2000-09-19 2005-07-16 Vitra Pharmaceuticals Ltd. Composiciones de hierro.
WO2006058426A1 (en) 2004-12-01 2006-06-08 Wlt Distributors Inc. Needle-free injector
US7585527B2 (en) * 2005-09-19 2009-09-08 Bala Venkataraman Composition and method for treating iron deficiency anemia
BRPI0712427B8 (pt) 2006-06-07 2021-06-22 Acushot Inc mecanismo de carregamento para um injetor sem agulha
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
CN102112167A (zh) 2008-03-07 2011-06-29 医用注射器公司 皮内注射器及其用途
EP2877848A4 (en) * 2012-07-27 2016-03-23 Intrinsic Life Sciences Llc METHOD FOR TREATING FERMENTED ANEMIA
EP2740492A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
JP5757493B1 (ja) * 2014-09-24 2015-07-29 富田製薬株式会社 経口型鉄分補給用固形組成物及びその製造方法
US10913705B2 (en) * 2014-11-07 2021-02-09 Npa—Núcleo De Pesquisas Aplicadas Ltda Iron amino acid compounds, method for preparing iron amino acid compounds, compositions containing iron amino acid compounds, and uses thereof
CN107753960B (zh) * 2016-08-19 2022-04-22 江苏纳菲生物医药科技有限公司 一种高分子-金属氧化物复合物及其制备方法与应用

Also Published As

Publication number Publication date
AU2019270428B2 (en) 2024-09-12
EP3793516A1 (en) 2021-03-24
CL2020002956A1 (es) 2021-04-30
WO2019219855A1 (en) 2019-11-21
US20210220319A1 (en) 2021-07-22
BR112020023212A2 (pt) 2021-02-23
AU2019270428A1 (en) 2020-11-26
JP2021523183A (ja) 2021-09-02
KR20210009332A (ko) 2021-01-26
CN112203639A (zh) 2021-01-08
CO2020015585A2 (es) 2021-03-19
UA128480C2 (uk) 2024-07-24
CA3099827A1 (en) 2019-11-21
PH12020551926A1 (en) 2021-06-14
EP3793516C0 (en) 2024-01-24
EP3793516B1 (en) 2024-01-24

Similar Documents

Publication Publication Date Title
MX2017013590A (es) Administracion de agente anticaspa soluble en surfactante.
SG10201908839QA (en) 2,4-dihydroxy-nicotinamides as apj agonists
WO2014191258A3 (en) Antimicrobial compositions comprising glyceryl ethers
EP4249916A3 (en) Compositions and methods for non-myeloablative conditioning
MY189454A (en) 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists
ECSP14033371A (es) Composiciones farmacéuticas y tratamiento de mastitis
MX2015012819A (es) Composiciones aglomerantes y metodos para fabricacion y utilizacion de las mismas.
GB2554296A (en) Antithrombin-heparin compositions and methods
PH12015500766A1 (en) Biocidal compositions comprising iron chelators
MX2017005065A (es) Composiciones que comprenden amonioalcanoatos de ester zwitterionico.
MX2021008839A (es) Composiciones aglomerantes y metodos para fabricacion y uso de las mismas.
MX2020007562A (es) Nuevas antranilamidas, su uso como insecticida y procesos para su preparacion.
MX2021015762A (es) Composiciones.
BR112018003173A2 (pt) lactama encapsulada, aditivo, composição e método de encapsulamento de uma lactama
PH12019501424A1 (en) Carboxylic acid aromatic amides as antagonists of bradykinin b1 receptor
BR112015013179A2 (pt) composição, kit, método para a preparação de uma composição e uso de um tensoativo com um hlb entre 1 e 8
MX2019010317A (es) Composiciones cosmeticas para el cuidado de la piel.
MX2019009759A (es) Composiciones de peptido estables.
MX2015012932A (es) Lamina de acero electrico de grano no orientado que tiene excelente propidad de perdida de hierro a alta frecuencia.
MX2018013276A (es) Composiciones antiadherentes y metodos para inhibir la adherencia de microbios a una superficie.
PH12020551926A1 (en) Veterinary compositions and the uses thereof for controlling iron deficiencies in non-human mammals
MX2018011837A (es) Composiciones y metodos para estabilizar alfavirus con formulaciones mejoradas.
FI20115692A0 (fi) Polymeerinen antimikrobinen lisäaine
MX2019003705A (es) Metodos, composiciones y usos relacionados con los mismos.
PH12020551893A1 (en) Preserved compositions